Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme.

Anttila A, Kotaniemi-Talonen L, Leinonen M, Hakama M, Laurila P, Tarkkanen J, Malila N, Nieminen P.

BMJ. 2010 Apr 27;340:c1804. doi: 10.1136/bmj.c1804.

2.

[Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].

Ronco G, Confortini M, Maccallini V, Naldoni C, Segnan N, Sideri M, Zappa M, Zorzi M, Calvia M, Giorgi Rossi P.

Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 2):e1-e33. Review. Italian.

3.

Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.

Arbyn M, Roelens J, Simoens C, Buntinx F, Paraskevaidis E, Martin-Hirsch PP, Prendiville WJ.

Cochrane Database Syst Rev. 2013 Mar 28;(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Review.

PMID:
23543559
4.

Evidence regarding human papillomavirus testing in secondary prevention of cervical cancer.

Arbyn M, Ronco G, Anttila A, Meijer CJ, Poljak M, Ogilvie G, Koliopoulos G, Naucler P, Sankaranarayanan R, Peto J.

Vaccine. 2012 Nov 20;30 Suppl 5:F88-99. doi: 10.1016/j.vaccine.2012.06.095. Review. Erratum in: Vaccine. 2013 Dec 16;31(52):6266.

PMID:
23199969
5.

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.

Cuzick J, Arbyn M, Sankaranarayanan R, Tsu V, Ronco G, Mayrand MH, Dillner J, Meijer CJ.

Vaccine. 2008 Aug 19;26 Suppl 10:K29-41. doi: 10.1016/j.vaccine.2008.06.019. Review.

PMID:
18847555
6.

Liquid-based cytology and human papillomavirus testing to screen for cervical cancer: a systematic review for the U.S. Preventive Services Task Force.

Whitlock EP, Vesco KK, Eder M, Lin JS, Senger CA, Burda BU.

Ann Intern Med. 2011 Nov 15;155(10):687-97, W214-5. doi: 10.7326/0003-4819-155-10-201111150-00376. Epub 2011 Oct 17. Review. Erratum in: Ann Intern Med. 2012 Jan 3;156(1 Pt 1):71-2.

PMID:
22006930
7.

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.

Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/78-89. Review.

PMID:
16950021
8.

Screening for cervical cancer: new alternatives and research.

Lörincz AT.

Salud Publica Mex. 2003;45 Suppl 3:S376-87. Review.

PMID:
14746031
9.

Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia.

Al-Mandeel HM, Sagr E, Sait K, Latifah HM, Al-Obaid A, Al-Badawi IA, Alkushi AO, Salem H, Massoudi NS, Schunemann H, Mustafa RA, Brignardello-Petersen R.

Ann Saudi Med. 2016 Sep-Oct;36(5):313-320. Review.

10.

Primary HPV screening for cervical cancer prevention: results from European trials.

Lynge E, Rebolj M.

Nat Rev Clin Oncol. 2009 Dec;6(12):699-706. doi: 10.1038/nrclinonc.2009.167. Epub 2009 Nov 10. Review.

PMID:
19901920
11.

Epidemiology and Early Detection of Cervical Cancer.

Hillemanns P, Soergel P, Hertel H, Jentschke M.

Oncol Res Treat. 2016;39(9):501-6. doi: 10.1159/000448385. Epub 2016 Aug 22. Review.

PMID:
27614953
12.

Performance of HPV DNA testing in the follow-up after treatment of high-grade cervical lesions, adenocarcinoma in situ (AIS) and microinvasive carcinoma.

Costa S, Venturoli S, Origoni M, Preti M, Mariani L, Cristoforoni P, Sandri MT.

Ecancermedicalscience. 2015 Apr 29;9:528. doi: 10.3332/ecancer.2015.528. eCollection 2015. Review.

13.

Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed?

Chung SH.

J Menopausal Med. 2016 Aug;22(2):65-70. doi: 10.6118/jmm.2016.22.2.65. Epub 2016 Aug 30. Review.

14.

The Danish Quality Database for Cervical Cancer Screening.

Rygaard C.

Clin Epidemiol. 2016 Oct 25;8:655-660. eCollection 2016. Review.

Supplemental Content

Support Center